Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Long

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Frontiers in Immunology|December 21, 2020
The JAK1 Selective Inhibitor ABT 317 Blocks Signaling Through Interferon-γ and Common γ Chain Cytokine Receptors to Reverse Autoimmune Diabetes in NOD MiceTingting Ge, Gaurang Jhala, Stacey Fynch, et al.
BMC Rheumatology|March 20, 2019
In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494)Julie M Parmentier, Jeff Voss, Candace Graff, et al.
Toxicologic Pathology|June 22, 2016
Syk Inhibition Induces Platelet Dependent Peri-islet Hemorrhage in the Rat PancreasAndrew J Long, Erik Sampson, Richard W McCarthy, et al.
Frontiers in Allergy|August 6, 2025
Shrimp oral immunotherapy outcomes in the phase 2 clinical trial: MOTIFShirley Y Jiang, Shu Cao, Kristine Martinez, et al.
Frontiers in Immunology|December 13, 2018
Analysis of a Large Standardized Food Challenge Data Set to Determine Predictors of Positive Outcome Across Multiple AllergensSayantani Sindher, Andrew J Long, Natasha Purington, et al.
Frontiers in Immunology|December 17, 2020
Corrigendum: Analysis of a Large Standardized Food Challenge Data Set to Determine Predictors of Positive Outcome Across Multiple AllergensSayantani Sindher, Andrew J Long, Natasha Purington, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 9, 2026
Biologics and Novel Therapeutics in Food AllergyBrent Anderson, Claire Pascal, M Gohazrua K Butler, et al.
Frontiers in Immunology|January 30, 2026
Targeted degradation of MK2 is insufficient to block inflammatory cytokine production in human cells due to cooperativity with MK3 and MK5Bin Yang, Guoqiang Fang, Isaac Marx, et al.
The Journal of Allergy and Clinical Immunology|November 14, 2025
Exploratory analyses of predictors and correlates of response to omalizumab therapy in patients with multiple food allergiesR Sharon Chinthrajah, Michael Kulis, Stacie M Jones, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Frontiers in Immunology|December 21, 2020
The JAK1 Selective Inhibitor ABT 317 Blocks Signaling Through Interferon-γ and Common γ Chain Cytokine Receptors to Reverse Autoimmune Diabetes in NOD MiceTingting Ge, Gaurang Jhala, Stacey Fynch, et al.
BMC Rheumatology|March 20, 2019
In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494)Julie M Parmentier, Jeff Voss, Candace Graff, et al.
Toxicologic Pathology|June 22, 2016
Syk Inhibition Induces Platelet Dependent Peri-islet Hemorrhage in the Rat PancreasAndrew J Long, Erik Sampson, Richard W McCarthy, et al.
Frontiers in Allergy|August 6, 2025
Shrimp oral immunotherapy outcomes in the phase 2 clinical trial: MOTIFShirley Y Jiang, Shu Cao, Kristine Martinez, et al.
Frontiers in Immunology|December 13, 2018
Analysis of a Large Standardized Food Challenge Data Set to Determine Predictors of Positive Outcome Across Multiple AllergensSayantani Sindher, Andrew J Long, Natasha Purington, et al.
Frontiers in Immunology|December 17, 2020
Corrigendum: Analysis of a Large Standardized Food Challenge Data Set to Determine Predictors of Positive Outcome Across Multiple AllergensSayantani Sindher, Andrew J Long, Natasha Purington, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 9, 2026
Biologics and Novel Therapeutics in Food AllergyBrent Anderson, Claire Pascal, M Gohazrua K Butler, et al.
Frontiers in Immunology|January 30, 2026
Targeted degradation of MK2 is insufficient to block inflammatory cytokine production in human cells due to cooperativity with MK3 and MK5Bin Yang, Guoqiang Fang, Isaac Marx, et al.
The Journal of Allergy and Clinical Immunology|November 14, 2025
Exploratory analyses of predictors and correlates of response to omalizumab therapy in patients with multiple food allergiesR Sharon Chinthrajah, Michael Kulis, Stacie M Jones, et al.
Pageof 3